Thank you for the question.
The website isn't ours anymore. We share it, coming together with the associations and others of the working group. We're very proud of our leadership role, but it is a joint effort. You can go through all the websites to get to the one. I think that was an important place. There were four up before, so people were confused about where they could find the best information.
We've all worked together. It's not a perfect model yet, but it's coming together so you can get the information. Let me tell you, I get notices and they're coming in all the time. So we're tracking that.
In terms of the first step, we're in good shape. Timely information is important. I do want to put a little caution to this, though, because I've also heard anecdotally that we have to be careful, when we're talking about so-called anticipated shortages, to watch out for human nature, behaviour of hoarding, protecting supply, and all of a sudden magnifying the problem we're talking about. That's a difficult thing. On one hand—I think HealthPRO mentioned it—you're trying to balance competitiveness, information, and supply, so it's that right balance that we're trying to get at. On the first part, I think we're in good shape.
Ultimately, my point was that we can have the best reporting in the world, but we need a new system, because drug shortages will occur for the multiplicity of reasons that we all listen for. If we don't have multiple suppliers—